Crefmirlimab Antibody
Crefmirlimab (89Zr-Df-IAB22M2C) is a radiolabeled diagnostic agent targeting the CD8 antigen, enabling the non-invasive imaging of CD8+ T-cells. It is utilized in preclinical and clinical research for monitoring immunotherapy responses and tracking T-cell infiltration in tumors via positron emission tomography (PET), applicable in both in vivo and in vitro studies.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62582R-PE-Cy5 100 µL
MAP3K4 Recombinant Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details 